Camberlogo1 (Camberlogo1)
Sildenafil Tablet, Film Coated
Product Images NDC 50090-5325
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 50090-5325). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Camberlogo2 (Camberlogo2)
Sildenafilfigure7 (Sildenafilfigure7)
A vertical bar chart displaying the percentage of patients reporting improvement across four treatment groups: placebo, Sildenafil Citrate Tablets 25 mg, 50 mg, and 100 mg. The chart shows increasing percentages of improvement with higher Sildenafil doses, from 24% for placebo to 82% for 100 mg Sildenafil Citrate Tablets.*
Label Image (Lbl500905325)
Sildenafil 100 mg film-coated tablets in a carton labeled by A-S Medication Solutions. The label states each film-coated tablet contains sildenafil citrate USP equivalent to 100 mg of sildenafil. Storage instructions specify to keep at 59 to 77 degrees Fahrenheit. The package contains 10 tablets, and includes the NDC 50090-5325-0 and product number 6804-0.*
Sildenafilfigure1 (Sildenafilfigure1)
A line graph showing the effect of Sildenafil 100 mg versus placebo on systolic blood pressure over 24 hours post-dose. The x-axis represents time in hours, and the y-axis represents systolic blood pressure in mmHg. Two lines compare blood pressure changes for Sildenafil and placebo groups.*
Sildenafilfigure2 (Sildenafilfigure2)
A line graph comparing the pharmacokinetic profiles of two formulations: Domacin & Placebo versus Domacin & Cilostazol 25 mg. The x-axis represents time postdose in hours, and the y-axis shows the change in a measured variable (mM/Mg). The graph tracks changes over approximately eight hours.*
Sildenafilfigure3 (Sildenafilfigure3)
A line graph showing changes in a measured variable over time postdose (hours). It compares data for two treatments: one marked by blue circles labeled 'Iloprost + Placebo' and another by black squares labeled 'Iloprost + Sildenafil 50 mg.' The y-axis represents the change in the measured variable (% change), while the x-axis represents time in hours from 0 to 8 hours.*
Sildenafilfigure4 (Sildenafilfigure4)
A time-course line graph comparing the effect of Doxazosin plus Sildenafil 100 mg versus Doxazosin plus placebo over an 8-hour period. The y-axis measures a variable in mmHg, and the x-axis indicates time after dosing in hours. Data points for both groups are plotted to show changes across time.*
Sildenafilfigure5 (Sildenafilfigure5)
A pharmacokinetic curve showing plasma concentration (ng/ml) on the vertical axis over time post dose (hours) on the horizontal axis for the commercial tablet treatment. The curve rises sharply to a peak concentration around 1 hour and then declines gradually over 24 hours.*
Sildenafilfigure6a (Sildenafilfigure6a)
A bar chart depicting the percentage of patients at endpoint according to baseline score categories ranging from 0 to 5. The legend includes six distinct score levels represented by different shading or color for each bar group, showing varying patient distribution percentages for each baseline score.*
Sildenafilfigure6b (Sildenafilfigure6b)
A bar chart showing the percentage of patients at endpoint across different baseline scores from 0 to 5. Each baseline score category contains stacked bars representing subcategories labeled 00, 1, 2, 3, 4, and 5, illustrating distribution percentages within these groups.*
Sildenafilheterologo1 (Sildenafilheterologo1)
Sildenafilheterologo2 (Sildenafilheterologo2)
Sildenafilstructure (Sildenafilstructure)
Chemical structure of sildenafil citrate showing the molecular arrangement of the active ingredient in the drug. The diagram includes labeled atoms and bonds representing the sildenafil molecule and its citrate component.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
